{
    "xml": "<topic id=\"PHP33676\" outputclass=\"drug\" rev=\"1.18\" type=\"drug\" namespace=\"/drugs/pertuzumab\" basename=\"pertuzumab\" title=\"PERTUZUMAB\">\n<title>PERTUZUMAB</title>\n<body>\n<data name=\"vtmid\">704227006</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_872447286\" title=\"Monoclonal antibodies (antineoplastic)\">Monoclonal antibodies (antineoplastic)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n</body>\n<topic id=\"PHP38540\" outputclass=\"drugAction\" rev=\"1.10\" parent=\"/drugs/pertuzumab\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>Pertuzumab is a recombinant humanised monoclonal antibody, and acts by inhibiting human epidermal growth factor receptor 2 protein (HER2) dimerisation.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38523\" outputclass=\"indicationsAndDose\" rev=\"1.13\" parent=\"/drugs/pertuzumab\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of HER2-positive metastatic or locally recurrent unresectable breast cancer in combination with trastuzumab and docetaxel, in patients who have not received previous anti-HER2 therapy or chemotherapy (initiated by a specialist)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>(consult product literature).</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38570\" outputclass=\"cautions\" rev=\"1.9\" parent=\"/drugs/pertuzumab\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Conditions that could impair left ventricular function</ph>; <ph outputclass=\"caution\">history of congestive heart failure</ph>; <ph outputclass=\"caution\">impaired left ventricular function</ph>; <ph outputclass=\"caution\">prior anthracycline exposure</ph>; <ph outputclass=\"caution\">radiotherapy to the chest area</ph>; <ph outputclass=\"caution\">recent myocardial infarction</ph>; <ph outputclass=\"caution\">serious cardiac arrhythmia</ph>; <ph outputclass=\"caution\">uncontrolled hypertension</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38509\" outputclass=\"interactions\" rev=\"1.8\" parent=\"/drugs/pertuzumab\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (pertuzumab).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38467\" outputclass=\"sideEffects\" rev=\"1.13\" parent=\"/drugs/pertuzumab\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Anaemia (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">arthralgia (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">chills (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">constipation (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">cough (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">decreased appetite (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">diarrhoea (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">dizziness (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">dry skin (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">dyspepsia (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">dyspnoea (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">febrile neutropenia (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">headache (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">increased lacrimation (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">infusion-related reactions (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">insomnia (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">left ventricular dysfunction (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">leucopenia (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">malaise (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">myalgia (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">nail disorder (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">nasopharyngitis (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">neutropenia (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">oedema (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">pain (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">paronychia (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">peripheral neuropathy (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">pleural effusion (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">pruritus (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">pyrexia (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">rash (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">severe hypersensitivity reactions (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">taste disturbance (when used in combination with trastuzumab and docetaxel)</ph>; <ph outputclass=\"sideEffect\">upper respiratory-tract infection (when used in combination with trastuzumab and docetaxel)</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Interstitial lung disease (when used in combination with trastuzumab and docetaxel)</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Alopecia</ph>; <ph outputclass=\"sideEffect\">bone-marrow suppression</ph>; <ph outputclass=\"sideEffect\">extravasation</ph>; <ph outputclass=\"sideEffect\">hyperuricaemia</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">oral mucositis</ph>; <ph outputclass=\"sideEffect\">thromboembolism</ph>; <ph outputclass=\"sideEffect\">tumour lysis syndrome</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38563\" outputclass=\"conceptionAndContraception\" parent=\"/drugs/pertuzumab\">\n<title>Conception and contraception</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Exclude pregnancy before treatment with cytotoxic drugs.</p>\n<p>Contraceptive advice should be given before cytotoxic therapy begins&#8212;ensure effective contraception during and for six months after treatment in women of childbearing potential.</p>\n<p>Regimens that do not contain an alkylating drug or procarbazine may have less effect on fertility, but those with an alkylating drug or procarbazine carry the risk of causing permanent male sterility (there is no effect on potency). Pretreatment counselling and consideration of sperm storage may be appropriate. Women are less severely affected, though the span of reproductive life may be shortened by the onset of a premature menopause. No increase in fetal abnormalities or abortion rate has been recorded in patients who remain fertile after cytotoxic chemotherapy.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38501\" outputclass=\"pregnancy\" parent=\"/drugs/pertuzumab\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid (toxicity in <i>animal</i> studies).</p>\n<p>Most cytotoxic drugs are teratogenic and should not be administered during pregnancy, especially during the first trimester.</p>\n<p>Considerable caution is necessary if a pregnant woman presents with cancer requiring chemotherapy, and specialist advice should always be sought.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38575\" outputclass=\"breastFeeding\" parent=\"/drugs/pertuzumab\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38531\" outputclass=\"hepaticImpairment\" parent=\"/drugs/pertuzumab\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Caution&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38490\" outputclass=\"renalImpairment\" parent=\"/drugs/pertuzumab\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Caution in severe impairment&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38435\" outputclass=\"monitoringRequirements\" parent=\"/drugs/pertuzumab\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Assess for signs and symptoms of congestive heart failure (including left ventricular ejection fraction) before and during treatment&#8212;consult product literature, and withhold treatment if necessary.</p>\n<p>Monitor for febrile neutropenia.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38590\" outputclass=\"directionsForAdministration\" rev=\"1.8\" parent=\"/drugs/pertuzumab\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>Resuscitation facilities should be available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP33676-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/pertuzumab\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75749\" title=\"Solution for infusion\" namespace=\"/drugs/pertuzumab/solution-for-infusion\">Solution for infusion</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75749\" namespace=\"/drugs/pertuzumab/solution-for-infusion\" title=\"Solution for infusion\" count=\"1\" rel=\"link\">Solution for infusion</xref>\n</links>\n</topic>",
    "id": "PHP33676",
    "outputclass": "drug",
    "rev": "1.18",
    "type": "drug",
    "namespace": "/drugs/pertuzumab",
    "basename": "pertuzumab",
    "title": "PERTUZUMAB",
    "vtmid": "704227006",
    "drugClassification": [
        "Monoclonal antibodies (antineoplastic)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "Pertuzumab is a recombinant humanised monoclonal antibody, and acts by inhibiting human epidermal growth factor receptor 2 protein (HER2) dimerisation.",
                "html": "<p>Pertuzumab is a recombinant humanised monoclonal antibody, and acts by inhibiting human epidermal growth factor receptor 2 protein (HER2) dimerisation.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Treatment of HER2-positive metastatic or locally recurrent unresectable breast cancer in combination with trastuzumab and docetaxel, in patients who have not received previous anti-HER2 therapy or chemotherapy (initiated by a specialist)",
                        "html": "Treatment of HER2-positive metastatic or locally recurrent unresectable breast cancer in combination with trastuzumab and docetaxel, in patients who have not received previous anti-HER2 therapy or chemotherapy (initiated by a specialist)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "(consult product literature).",
                        "html": "<p>(consult product literature).</p>"
                    }
                ]
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Conditions that could impair left ventricular function",
                "html": "Conditions that could impair left ventricular function"
            },
            {
                "type": "cautions",
                "textContent": "history of congestive heart failure",
                "html": "history of congestive heart failure"
            },
            {
                "type": "cautions",
                "textContent": "impaired left ventricular function",
                "html": "impaired left ventricular function"
            },
            {
                "type": "cautions",
                "textContent": "prior anthracycline exposure",
                "html": "prior anthracycline exposure"
            },
            {
                "type": "cautions",
                "textContent": "radiotherapy to the chest area",
                "html": "radiotherapy to the chest area"
            },
            {
                "type": "cautions",
                "textContent": "recent myocardial infarction",
                "html": "recent myocardial infarction"
            },
            {
                "type": "cautions",
                "textContent": "serious cardiac arrhythmia",
                "html": "serious cardiac arrhythmia"
            },
            {
                "type": "cautions",
                "textContent": "uncontrolled hypertension",
                "html": "uncontrolled hypertension"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (pertuzumab).",
                "html": "<p>Appendix 1 (pertuzumab).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Anaemia (when used in combination with trastuzumab and docetaxel)",
                        "html": "Anaemia (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "arthralgia (when used in combination with trastuzumab and docetaxel)",
                        "html": "arthralgia (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "chills (when used in combination with trastuzumab and docetaxel)",
                        "html": "chills (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "constipation (when used in combination with trastuzumab and docetaxel)",
                        "html": "constipation (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "cough (when used in combination with trastuzumab and docetaxel)",
                        "html": "cough (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "decreased appetite (when used in combination with trastuzumab and docetaxel)",
                        "html": "decreased appetite (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "diarrhoea (when used in combination with trastuzumab and docetaxel)",
                        "html": "diarrhoea (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dizziness (when used in combination with trastuzumab and docetaxel)",
                        "html": "dizziness (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dry skin (when used in combination with trastuzumab and docetaxel)",
                        "html": "dry skin (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dyspepsia (when used in combination with trastuzumab and docetaxel)",
                        "html": "dyspepsia (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dyspnoea (when used in combination with trastuzumab and docetaxel)",
                        "html": "dyspnoea (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "febrile neutropenia (when used in combination with trastuzumab and docetaxel)",
                        "html": "febrile neutropenia (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache (when used in combination with trastuzumab and docetaxel)",
                        "html": "headache (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "increased lacrimation (when used in combination with trastuzumab and docetaxel)",
                        "html": "increased lacrimation (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "infusion-related reactions (when used in combination with trastuzumab and docetaxel)",
                        "html": "infusion-related reactions (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "insomnia (when used in combination with trastuzumab and docetaxel)",
                        "html": "insomnia (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "left ventricular dysfunction (when used in combination with trastuzumab and docetaxel)",
                        "html": "left ventricular dysfunction (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "leucopenia (when used in combination with trastuzumab and docetaxel)",
                        "html": "leucopenia (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "malaise (when used in combination with trastuzumab and docetaxel)",
                        "html": "malaise (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "myalgia (when used in combination with trastuzumab and docetaxel)",
                        "html": "myalgia (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nail disorder (when used in combination with trastuzumab and docetaxel)",
                        "html": "nail disorder (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nasopharyngitis (when used in combination with trastuzumab and docetaxel)",
                        "html": "nasopharyngitis (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "neutropenia (when used in combination with trastuzumab and docetaxel)",
                        "html": "neutropenia (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "oedema (when used in combination with trastuzumab and docetaxel)",
                        "html": "oedema (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pain (when used in combination with trastuzumab and docetaxel)",
                        "html": "pain (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "paronychia (when used in combination with trastuzumab and docetaxel)",
                        "html": "paronychia (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "peripheral neuropathy (when used in combination with trastuzumab and docetaxel)",
                        "html": "peripheral neuropathy (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pleural effusion (when used in combination with trastuzumab and docetaxel)",
                        "html": "pleural effusion (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pruritus (when used in combination with trastuzumab and docetaxel)",
                        "html": "pruritus (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pyrexia (when used in combination with trastuzumab and docetaxel)",
                        "html": "pyrexia (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "rash (when used in combination with trastuzumab and docetaxel)",
                        "html": "rash (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "severe hypersensitivity reactions (when used in combination with trastuzumab and docetaxel)",
                        "html": "severe hypersensitivity reactions (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "taste disturbance (when used in combination with trastuzumab and docetaxel)",
                        "html": "taste disturbance (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "upper respiratory-tract infection (when used in combination with trastuzumab and docetaxel)",
                        "html": "upper respiratory-tract infection (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Interstitial lung disease (when used in combination with trastuzumab and docetaxel)",
                        "html": "Interstitial lung disease (when used in combination with trastuzumab and docetaxel)",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Alopecia",
                        "html": "Alopecia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "bone-marrow suppression",
                        "html": "bone-marrow suppression",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "extravasation",
                        "html": "extravasation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hyperuricaemia",
                        "html": "hyperuricaemia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "oral mucositis",
                        "html": "oral mucositis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "thromboembolism",
                        "html": "thromboembolism",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "tumour lysis syndrome",
                        "html": "tumour lysis syndrome",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "conceptionAndContraception": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Exclude pregnancy before treatment with cytotoxic drugs.\n\nContraceptive advice should be given before cytotoxic therapy begins&#8212;ensure effective contraception during and for six months after treatment in women of childbearing potential.\n\nRegimens that do not contain an alkylating drug or procarbazine may have less effect on fertility, but those with an alkylating drug or procarbazine carry the risk of causing permanent male sterility (there is no effect on potency). Pretreatment counselling and consideration of sperm storage may be appropriate. Women are less severely affected, though the span of reproductive life may be shortened by the onset of a premature menopause. No increase in fetal abnormalities or abortion rate has been recorded in patients who remain fertile after cytotoxic chemotherapy.",
                "html": "<p>Exclude pregnancy before treatment with cytotoxic drugs.</p><p>Contraceptive advice should be given before cytotoxic therapy begins&#8212;ensure effective contraception during and for six months after treatment in women of childbearing potential.</p><p>Regimens that do not contain an alkylating drug or procarbazine may have less effect on fertility, but those with an alkylating drug or procarbazine carry the risk of causing permanent male sterility (there is no effect on potency). Pretreatment counselling and consideration of sperm storage may be appropriate. Women are less severely affected, though the span of reproductive life may be shortened by the onset of a premature menopause. No increase in fetal abnormalities or abortion rate has been recorded in patients who remain fertile after cytotoxic chemotherapy.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid (toxicity in animal studies).\n\nMost cytotoxic drugs are teratogenic and should not be administered during pregnancy, especially during the first trimester.\n\nConsiderable caution is necessary if a pregnant woman presents with cancer requiring chemotherapy, and specialist advice should always be sought.",
                "html": "<p>Avoid (toxicity in <i>animal</i> studies).</p><p>Most cytotoxic drugs are teratogenic and should not be administered during pregnancy, especially during the first trimester.</p><p>Considerable caution is necessary if a pregnant woman presents with cancer requiring chemotherapy, and specialist advice should always be sought.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid&#8212;no information available.",
                "html": "<p>Avoid&#8212;no information available.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Caution&#8212;no information available.",
                "html": "<p>Caution&#8212;no information available.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Caution in severe impairment&#8212;no information available.",
                "html": "<p>Caution in severe impairment&#8212;no information available.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Assess for signs and symptoms of congestive heart failure (including left ventricular ejection fraction) before and during treatment&#8212;consult product literature, and withhold treatment if necessary.\n\nMonitor for febrile neutropenia.",
                "html": "<p>Assess for signs and symptoms of congestive heart failure (including left ventricular ejection fraction) before and during treatment&#8212;consult product literature, and withhold treatment if necessary.</p><p>Monitor for febrile neutropenia.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "Resuscitation facilities should be available.",
                "html": "<p>Resuscitation facilities should be available.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75749",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75749",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            }
        ]
    }
}